Literature DB >> 15877667

QT interval dispersion in dialysis patients.

Vin-Cent Wu1, Lian-Yu Lin, Kwan-Dun Wu.   

Abstract

The leading cause of mortality in dialysis patients is cardiovascular complications, including ventricular arrhythmias and sudden cardiac death. A reliable non-invasive predictive test of sudden death is therefore important. The interlead variation in duration of the QT interval on the surface electrocardiogram corrected with heart rate (QTc dispersion) might serve as a surrogate for ventricular arrhythmia. Prolonged QTc dispersion is commonly encountered in dialysis patients and possesses an increased risk of all mortality, including cardiovascular mortality. QT dispersion might be affected by shifts of the intracellular electrolytes during dialysis and increasing deposition of iron in cardiac muscles in these patients who have underlying heart diseases. Although no well-designed study has been done, the factors contributing to prolongation of QTc dispersion should be avoided. We summarize the results of the currently available clinical studies that examined QTc dispersion in dialysis patients.

Entities:  

Mesh:

Year:  2005        PMID: 15877667     DOI: 10.1111/j.1440-1797.2005.00391.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  16 in total

1.  Impact of Iron and Homocysteine Levels on T Peak-to-End Interval and Tp-e/QT Ratio in Elite Athletes.

Authors:  Serkan Duyuler; Pınar Türker Duyuler; Mustafa Kemal Batur
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-28       Impact factor: 1.468

2.  Changes in QT interval before and after hemodialysis.

Authors:  Mohammad Reza Khosoosi Niaki; Mehrdad Saravi; Farshid Oliaee; Roghayeh Akbari; Sepideh Noorkhomami; Seyed Hassan Bozorgi Rad; Kobra Fallahpoor; Mir Saeed Ramezani
Journal:  Caspian J Intern Med       Date:  2013

3.  Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients.

Authors:  Cindy You; Shishir Sharma; Aakash Bavishi; Christopher A Groh; Yazan Alia; Basil Saour; Rod Passman
Journal:  J Interv Card Electrophysiol       Date:  2018-03-10       Impact factor: 1.900

4.  QTc Interval and QT Dispersion in Patients with Thalassemia Major: Electrocardiographic (EKG) and Echocardiographic Evaluation.

Authors:  Taysir S Garadah; Salah Kassab; Najat Mahdi; Ahmed Abu-Taleb; Anwer Jamsheer
Journal:  Clin Med Insights Cardiol       Date:  2010-03-18

5.  The effect of hemodialysis on electrocardiographic parameters.

Authors:  Ramazan Astan; Ibrahim Akpinar; Adnan Karan; Fehmi Kacmaz; Erdogan Sokmen; Erkan Baysal; Ozcan Ozeke; Mehmet Timur Selçuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09-09       Impact factor: 1.468

6.  Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients.

Authors:  Biagio Di Iorio; Emanuele Cucciniello
Journal:  Clin Pharmacol       Date:  2010-06-01

Review 7.  QT interval in CKD and haemodialysis patients.

Authors:  Biagio Di Iorio; Antonio Bellasi
Journal:  Clin Kidney J       Date:  2013-01-17

8.  Pain frequency, severity and QT dispersion in adult patients with sickle cell anemia: correlation with inflammatory markers.

Authors:  Taysir S Garadah; Ahmed A Jaradat; Mohammed E AlAlawi; Adla B Hassan; Reginald P Sequeira
Journal:  J Blood Med       Date:  2016-10-31

9.  QT dispersion increases with low glomerular filtration rate in patients with coronary artery disease.

Authors:  Murat Celik; Uygarcagdas Yuksel; Yalcin Gokoglan; Baris Bugan; Emre Yalcinkaya; Hilmiumut Unal; Turgay Celik; Atila Iyisoy; Selim Kilic
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

10.  Comparison of Tpe Changing on ECG, in Pre and Post Dialysis and Post Transplantation.

Authors:  Ali Monfared; Mohammad Assadian Rad; Mohammadreza Feizkhah; Ehsan Kazemnezhad; Samaneh Esmaeili; Nadia Rastjou Herfeh; Razieh Hedayatsafa
Journal:  Nephrourol Mon       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.